{"id":4117,"date":"2019-02-18T10:59:52","date_gmt":"2019-02-18T05:29:52","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=4117"},"modified":"2024-06-12T15:54:58","modified_gmt":"2024-06-12T10:24:58","slug":"human-cells-reprogrammed-to-create-insulin-in-diabetic-mice","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice","title":{"rendered":"\ufeffHuman cells reprogrammed to create insulin in diabetic mice"},"content":{"rendered":"\n

Diabetes<\/strong> \u2013 a chronic condition in which sugar is not processed in the body. Diabetic people either do not produce enough insulin or cells halt responding to insulin<\/a><\/strong>. Due to this, sugar <\/strong>keeps on accumulating in the blood that leads to increased sugar. Gradually, high blood sugar can lead to nerve damage and heart disease among other complications. Nearly 10 percent<\/strong> of Americans have diabetes<\/a><\/strong>.<\/p>\n\n\n\n

Now scientists have reprogrammed human cells<\/strong> to produce the main hormone<\/a><\/strong>. The reprogrammed cells reversed diabetes in mice. This shows that human cells can take on various identities that will open up a new way to treat deteriorating diseases.<\/p>\n\n\n\n

Pedro Herrera<\/strong>, a medical geneticist at the University of Geneva in Switzerland<\/strong>, who took the lead in the new research, had said in a statement -\u201cThe idea of using the intrinsic regenerative capacities of the human body makes sense here\u201d.<\/p>\n\n\n\n

Convertible Cells<\/strong><\/p>\n\n\n\n

There are special cells in the pancreas called beta cells<\/strong> that are accountable for producing insulin. When beta cells are not there in mice, then<\/g> other cells like alpha cells and delta cells<\/strong>, emulate like beta cells and commence making insulin. However, if cells other than beta cells can switch in humans was mysterious.<\/p>\n\n\n\n

Herrera and\ncolleagues took two types of non-beta pancreatic cells from dead type 2\ndiabetic and non-diabetic people. Then, they reprogrammed the cells to generate\nand release insulin in response to sugar.<\/p>\n\n\n\n

New Act<\/strong><\/p>\n\n\n\n

When the scientists\ntransplanted the modified cells into diabetic mice, they prohibited\ndiabetic symptoms and continued to make insulin even after six months.<\/p>\n\n\n\n

Herrera said -\u201cWe obtained the same results with cells from both diabetic and non-diabetic donors, showing that this plasticity is not damaged by the disease,\u201d<\/p>\n\n\n\n

This gives a clue that human cells <\/strong>can take on various identities. The scientists propose that the cells are adaptable in other organs as well. The scientists suggest substituting absent cells with reprogrammed ones. This may be one approach to treat degenerative diseases<\/strong>.<\/p>\n\n\n\n

This hasn\u2019t been tested in humans yet, though the results in rodents are certainly promising<\/strong>. <\/p>\n","protected":false},"excerpt":{"rendered":"

Diabetes \u2013 a chronic condition in which sugar is not processed in the body. Diabetic people either do not produce enough insulin or cells halt responding to insulin. Due to this, sugar keeps on accumulating in the blood that leads to increased sugar. Gradually, high blood sugar can lead to nerve damage and heart disease […]<\/p>\n","protected":false},"author":1,"featured_media":4120,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[2578,2577,812,2574,2579,2575,2576,2580],"industry":[17225],"therapeutic_areas":[17235,17240],"class_list":["post-4117","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-beta-cells","tag-degenerative-diseases","tag-diabetes","tag-insulin","tag-pedro-herrera","tag-reprogrammed-human-cells","tag-treat-the-degenerativ","tag-university-of-geneva","industry-pharmaceutical","therapeutic_areas-cell-and-gene-therapy","therapeutic_areas-endocrinology-and-metabolic-disorders"],"acf":[],"yoast_head":"\nHuman cells reprogrammed to create insulin | Analysis and Insights<\/title>\n<meta name=\"description\" content=\"Diabetes is a chronic condition in which sugar is not processed in the body. Diabetic people either do not produce enough insulin\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Human cells reprogrammed to create insulin | Analysis and Insights\" \/>\n<meta property=\"og:description\" content=\"Diabetes is a chronic condition in which sugar is not processed in the body. Diabetic people either do not produce enough insulin\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-18T05:29:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-12T10:24:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021656\/Reversing-Type-I-Diabetes-with-an-Encapsulated-Cell-Technology-Interview-with-Gary-Harlem-CEO-of-Altucell-Depositphotos_103108188_m-2015.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"609\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Human cells reprogrammed to create insulin | Analysis and Insights","description":"Diabetes is a chronic condition in which sugar is not processed in the body. Diabetic people either do not produce enough insulin","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice","og_locale":"en_US","og_type":"article","og_title":"Human cells reprogrammed to create insulin | Analysis and Insights","og_description":"Diabetes is a chronic condition in which sugar is not processed in the body. Diabetic people either do not produce enough insulin","og_url":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-02-18T05:29:52+00:00","article_modified_time":"2024-06-12T10:24:58+00:00","og_image":[{"width":1000,"height":609,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021656\/Reversing-Type-I-Diabetes-with-an-Encapsulated-Cell-Technology-Interview-with-Gary-Harlem-CEO-of-Altucell-Depositphotos_103108188_m-2015.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice","url":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice","name":"Human cells reprogrammed to create insulin | Analysis and Insights","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021656\/Reversing-Type-I-Diabetes-with-an-Encapsulated-Cell-Technology-Interview-with-Gary-Harlem-CEO-of-Altucell-Depositphotos_103108188_m-2015.jpg","datePublished":"2019-02-18T05:29:52+00:00","dateModified":"2024-06-12T10:24:58+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Diabetes is a chronic condition in which sugar is not processed in the body. Diabetic people either do not produce enough insulin","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/human-cells-reprogrammed-to-create-insulin-in-diabetic-mice#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021656\/Reversing-Type-I-Diabetes-with-an-Encapsulated-Cell-Technology-Interview-with-Gary-Harlem-CEO-of-Altucell-Depositphotos_103108188_m-2015.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021656\/Reversing-Type-I-Diabetes-with-an-Encapsulated-Cell-Technology-Interview-with-Gary-Harlem-CEO-of-Altucell-Depositphotos_103108188_m-2015.jpg","width":1000,"height":609,"caption":"Diabetes"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021656\/Reversing-Type-I-Diabetes-with-an-Encapsulated-Cell-Technology-Interview-with-Gary-Harlem-CEO-of-Altucell-Depositphotos_103108188_m-2015-300x183.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">beta cells<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">degenerative diseases<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Diabetes<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">insulin<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pedro Herrera<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">reprogrammed human cells<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">treat the degenerativ<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">University of Geneva<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">beta cells<\/span>","<span class=\"advgb-post-tax-term\">degenerative diseases<\/span>","<span class=\"advgb-post-tax-term\">Diabetes<\/span>","<span class=\"advgb-post-tax-term\">insulin<\/span>","<span class=\"advgb-post-tax-term\">Pedro Herrera<\/span>","<span class=\"advgb-post-tax-term\">reprogrammed human cells<\/span>","<span class=\"advgb-post-tax-term\">treat the degenerativ<\/span>","<span class=\"advgb-post-tax-term\">University of Geneva<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on Feb 18, 2019","modified":"Updated on Jun 12, 2024"},"absolute_dates_time":{"created":"Posted on Feb 18, 2019 10:59 am","modified":"Updated on Jun 12, 2024 3:54 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=4117"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4117\/revisions"}],"predecessor-version":[{"id":28276,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4117\/revisions\/28276"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/4120"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=4117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=4117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=4117"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=4117"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=4117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}